IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients

doi:10.3748/wjg.v19.i2.290

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4194)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

408

HTML

3298

Figures (1-4)

268

Tables (1-2)

220

Sum=4194

Jan 14, 2013 (publication date) through Jan 30, 2025

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jan 14, 2013; 19(2): 290-298
Published online Jan 14, 2013. doi: 10.3748/wjg.v19.i2.290

Full Size Figure Download Figure

Figure 4 Sorting of C/T genotype according to association with cytomegalovirus infection. The sustained viral response (SVR) rates among C/T carriers, is reduced to < 50% of its value in cases where patients had cytomegalovirus (CMV) reactivation. On the other hand, the non-response rate is increased 2-fold in cases of CMV reactivation. HCV: Hepatitis C virus.

Citation: El Awady MK, Bader El Din NG, Tabll A, El Hosary Y, Abdel Aziz AO, El Khayat H, Salama M, Abdelhafez TH. IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients. World J Gastroenterol 2013; 19(2): 290-298
URL: https://www.wjgnet.com/1007-9327/full/v19/i2/290.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i2.290